Amanote Research
Register
Sign In
Smoking at Diagnosis Significantly Decreases 5-Year Cancer-Specific Survival in a Population-Based Cohort of 18 166 Colon Cancer Patients
Alimentary Pharmacology and Therapeutics
- United Kingdom
doi 10.1111/apt.13944
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hepatology
Pharmacology
Gastroenterology
Date
February 8, 2017
Authors
L. Sharp
J. McDevitt
C. Brown
H. Comber
Publisher
Wiley
Related search
Treatment at Academic Centers Decreases Insurance-Based Survival Disparities in Colon Cancer
Journal of Surgical Research
Surgery
Editorial: Smoking Status and 5-Year Survival in Patients With Colorectal Cancer
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Statin Use After Esophageal Cancer Diagnosis and Survival: A Population Based Cohort Study
Cancer Epidemiology
Cancer Research
Epidemiology
Oncology
Colon Cancer 5-Year Net Survival (%), Adults (15-99 Years), 2010-14
Health at a Glance: Asia/Pacific
Optimal Adjuvant Endocrine Treatment of ER+/HER2+ Breast Cancer Patients by Age at Diagnosis: A Population-Based Cohort Study
European Journal of Cancer
Cancer Research
Oncology
Commonly Used Medications and Endometrial Cancer Survival: A Population-Based Cohort Study
British Journal of Cancer
Cancer Research
Oncology
Parental Cancer Diagnosis and Child Mortality—A Population-Based Cohort Study in Sweden
Cancer Epidemiology
Cancer Research
Epidemiology
Oncology
Influence of Psychological Response on Survival in Breast Cancer: A Population-Based Cohort Study
The Lancet
Medicine
Comorbidity and Survival of Danish Lung Cancer Patients From 2000–2011: A Population-Based Cohort Study
Clinical Epidemiology
Epidemiology